X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3121) 3121
Publication (402) 402
Book Chapter (15) 15
Book Review (9) 9
Book / eBook (8) 8
Conference Proceeding (6) 6
Reference (2) 2
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2636) 2636
neurosciences (1347) 1347
male (1274) 1274
humans (1121) 1121
mice (1081) 1081
rats (987) 987
index medicus (955) 955
motor neurons - enzymology (869) 869
female (738) 738
neurons (509) 509
superoxide dismutase - genetics (509) 509
amyotrophic lateral sclerosis - enzymology (466) 466
amyotrophic lateral sclerosis (453) 453
disease models, animal (443) 443
immunohistochemistry (399) 399
biochemistry & molecular biology (398) 398
spinal cord - enzymology (386) 386
mice, transgenic (384) 384
neurons - enzymology (381) 381
amyotrophic-lateral-sclerosis (361) 361
mutation (361) 361
amyotrophic lateral sclerosis - genetics (358) 358
rats, sprague-dawley (344) 344
motor activity - drug effects (334) 334
superoxide dismutase - metabolism (330) 330
superoxide dismutase-1 (311) 311
brain (299) 299
cell biology (296) 296
motor neurons - pathology (287) 287
motor neurons - physiology (286) 286
mice, inbred c57bl (279) 279
motor neurons (276) 276
research (258) 258
histocytochemistry (255) 255
clinical neurology (253) 253
motor-neurons (241) 241
nervous system (232) 232
amyotrophic lateral sclerosis - pathology (229) 229
cells, cultured (229) 229
brain - enzymology (226) 226
motor neurons - drug effects (225) 225
oxidative stress (224) 224
multidisciplinary sciences (223) 223
rats, wistar (221) 221
proteins (219) 219
time factors (214) 214
physiological aspects (210) 210
motor neurons - cytology (209) 209
als (208) 208
expression (208) 208
middle aged (205) 205
neurology (204) 204
research article (199) 199
spinal cord - cytology (198) 198
analysis (192) 192
motor neurons - metabolism (192) 192
spinal cord (192) 192
spinal cord - pathology (188) 188
enzymes (186) 186
adult (184) 184
superoxide dismutase (184) 184
acetylcholinesterase - metabolism (179) 179
mice, knockout (179) 179
motor activity - physiology (178) 178
apoptosis (176) 176
spinal-cord (175) 175
genetic aspects (172) 172
transgenic mice (170) 170
rodents (169) 169
rat (167) 167
pharmacology & pharmacy (165) 165
neurodegeneration (164) 164
mouse model (162) 162
article (160) 160
aged (159) 159
phosphorylation (157) 157
disease (148) 148
choline o-acetyltransferase - metabolism (147) 147
medicine (146) 146
muscles - enzymology (145) 145
neurons - drug effects (141) 141
nervous system diseases (139) 139
motor activity (135) 135
degeneration (134) 134
tyrosine 3-monooxygenase - metabolism (134) 134
phenotype (133) 133
motor-neuron disease (132) 132
alzheimers-disease (129) 129
muscles - innervation (128) 128
physiology (128) 128
cells (127) 127
enzyme inhibitors - pharmacology (127) 127
nitric oxide (126) 126
neuroscience (124) 124
molecular sequence data (123) 123
motor-neuron degeneration (122) 122
parkinson's disease (122) 122
in-vivo (121) 121
mutations (119) 119
neurons - metabolism (119) 119
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3014) 3014
Russian (54) 54
German (20) 20
French (14) 14
Japanese (8) 8
Polish (6) 6
Italian (5) 5
Chinese (3) 3
Hungarian (2) 2
Czech (1) 1
Danish (1) 1
Hebrew (1) 1
Spanish (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Cell Biology, ISSN 0021-9525, 12/2009, Volume 187, Issue 6, pp. 761 - 772
Selective degeneration and death of one or more classes of neurons is the defining feature of human neurodegenerative disease. Although traditionally viewed as... 
Motor neurons | Nervous system diseases | Reviews | Neurodegenerative diseases | Neurons | Astrocytes | Motor neuron disease | Huntington disease | Parkinson disease | Amyotrophic lateral sclerosis | Prion diseases | CU/ZN-SUPEROXIDE-DISMUTASE | GLUTAMATE TRANSPORTER EAAT2 | MOTOR-NEURON DEGENERATION | SLOW DISEASE PROGRESSION | MONOAMINE-OXIDASE-B | LINKED SOD1 MUTANTS | AMYOTROPHIC-LATERAL-SCLEROSIS | FRONTOTEMPORAL LOBAR DEGENERATION | TRANSGENIC MOUSE MODEL | GENOME-WIDE ASSOCIATION | CELL BIOLOGY | Neurons - pathology | Axonal Transport | Superoxide Dismutase - genetics | Capillaries - pathology | T-Lymphocytes - enzymology | Humans | Astrocytes - pathology | Stress, Physiological | Nerve Degeneration - genetics | Astrocytes - enzymology | Endoplasmic Reticulum - pathology | Cell Death | Superoxides - metabolism | Microglia - pathology | Amyotrophic Lateral Sclerosis - enzymology | T-Lymphocytes - pathology | Superoxide Dismutase - metabolism | Endoplasmic Reticulum - enzymology | Nerve Degeneration - enzymology | Amyotrophic Lateral Sclerosis - genetics | Microglia - enzymology | Capillaries - enzymology | Nerve Degeneration - pathology | Amyotrophic Lateral Sclerosis - pathology | Animals | Neurons - enzymology | Glutamic Acid - metabolism | Mutation | Superoxide Dismutase-1 | Care and treatment | Physiological aspects | Superoxide dismutase | Genetic aspects | Disease susceptibility | Research | Health aspects | Index Medicus
Journal Article
Cell Stem Cell, ISSN 1934-5909, 06/2013, Volume 12, Issue 6, pp. 713 - 726
Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease, characterized by motor neuron (MN) death, for which there are no truly... 
SURVIVAL | MATRIX METALLOPROTEINASES | PROTEIN-KINASE | TDP-43 | MOUSE MODEL | DEATH | AMYOTROPHIC-LATERAL-SCLEROSIS | FRONTOTEMPORAL LOBAR DEGENERATION | C-JUN | DISEASE PROGRESSION | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Superoxide Dismutase - genetics | Embryonic Stem Cells - cytology | Humans | Intracellular Signaling Peptides and Proteins - metabolism | Structure-Activity Relationship | Amyotrophic Lateral Sclerosis - drug therapy | Protein Kinase Inhibitors - chemistry | Protein Kinase Inhibitors - analysis | Motor Neurons - cytology | Cholestenones - chemistry | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Indoles - pharmacology | Amyotrophic Lateral Sclerosis - enzymology | Induced Pluripotent Stem Cells - cytology | Motor Neurons - drug effects | Protein-Serine-Threonine Kinases - metabolism | Superoxide Dismutase - metabolism | Cell Survival - drug effects | Glycogen Synthase Kinase 3 - antagonists & inhibitors | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Cells, Cultured | Mice, Transgenic | Benzazepines - pharmacology | Motor Neurons - enzymology | Glycogen Synthase Kinase 3 - metabolism | Amyotrophic Lateral Sclerosis - pathology | Animals | Cell Differentiation - drug effects | Cholestenones - pharmacology | Mice | Protein Kinase Inhibitors - pharmacology | Mutation | Superoxide Dismutase-1 | Benzazepines - chemistry | Indoles - chemistry
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 05/2013, Volume 288, Issue 22, pp. 15699 - 15711
Journal Article
Experimental Neurology, ISSN 0014-4886, 09/2012, Volume 237, Issue 1, pp. 147 - 152
Journal Article
Brain, ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3355 - 3370
Axonal degeneration is one of the earliest features of Parkinson's disease pathology, which is followed by neuronal death in the substantia nigra and other... 
axonal degeneration | Parkinson's disease | rho kinase | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | dopaminergic cell death | CONTROLLED-TRIAL | SIGNALING PATHWAYS | REGENERATION | SUBSTANTIA-NIGRA | NEUROSCIENCES | CLINICAL NEUROLOGY | CELL-DEATH | COENZYME Q | IN-VITRO | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP | NEURITE OUTGROWTH | DOUBLE-BLIND | Neuroprotective Agents - therapeutic use | Rats, Wistar | Dopaminergic Neurons - pathology | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Male | Corpus Striatum - metabolism | Nerve Degeneration - chemically induced | Neuroprotective Agents - metabolism | rho-Associated Kinases - antagonists & inhibitors | Parkinson Disease, Secondary - pathology | Neuroprotective Agents - pharmacology | Parkinson Disease, Secondary - drug therapy | Dopaminergic Neurons - physiology | Behavior, Animal - drug effects | Parkinson Disease, Secondary - chemically induced | Proto-Oncogene Proteins c-akt - metabolism | Cell Survival - physiology | Dopamine - metabolism | Disease Models, Animal | Substantia Nigra - enzymology | Cell Survival - drug effects | rho-Associated Kinases - physiology | Nerve Degeneration - enzymology | Mice, Inbred C57BL | Cells, Cultured | Axons - drug effects | Rats | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - therapeutic use | Behavior, Animal - physiology | MPTP Poisoning - drug therapy | MPTP Poisoning - enzymology | Parkinson Disease, Secondary - enzymology | Neurites - pathology | Dopaminergic Neurons - enzymology | Substantia Nigra - drug effects | Animals | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Axons - pathology | 1-Methyl-4-phenylpyridinium - toxicity | Mice | Nerve Degeneration - drug therapy | Proto-Oncogene Proteins c-akt - drug effects | Cell culture | Neuroprotection | Animal models | Cell survival | Dopamine | Neurodegenerative diseases | Substantia nigra | Central nervous system | AKT protein | Motor task performance | Rho-associated kinase | Axons | Regeneration | Metabolites | Neurodegeneration | Neostriatum | Axon guidance | Movement disorders
Journal Article
Journal Article
Journal of Cell Biology, ISSN 0021-9525, 11/2017, Volume 216, Issue 11, pp. 3655 - 3675
Axon degeneration is an early event and pathological in neurodegenerative conditions and nerve injuries. To discover agents that suppress neuronal death and... 
NEURONAL APOPTOSIS | AXON DEGENERATION | WALLERIAN DEGENERATION | SYMPATHETIC NEURONS | INHIBITOR FORETINIB | CYTOCHROME-C RELEASE | RECEPTOR TYROSINE-KINASE | NERVE GROWTH-FACTOR | CELL-DEATH | STATISTICAL-MODEL | CELL BIOLOGY
Journal Article
Journal Article
Journal Article
Journal Article